Literature DB >> 33557317

A Study of Blood Fatty Acids Profile in Hyperlipidemic and Normolipidemic Subjects in Association with Common PNPLA3 and ABCB1 Polymorphisms.

Thomai Mouskeftara1,2, Antonis Goulas3, Despoina Ioannidou3, Charikleia Ntenti3, Dimitris Agapakis4, Andreana Assimopoulou5,6, Helen Gika1,2.   

Abstract

Adiponutrin (patatin-like phospholipase domain-containing 3; PNPLA3), encoded in humans by the PNPLA3 gene, is a protein associated with lipid droplet and endoplasmic reticulum membranes, where it is apparently involved in fatty acid redistribution between triglycerides and phospholipids. A common polymorphism of PNPLA3 (I148M, rs738409), linked to increased PNPLA3 presence on lipid droplets, is a strong genetic determinant of non-alcoholic fatty liver disease (NAFLD) and of its progression. P-glycoprotein (Pgp, MDR1, ABCB1), encoded by the ABCB1 gene, is another membrane protein implicated in lipid homeostasis and steatosis. In the past, common ABCB1 polymorphisms have been associated with the distribution of serum lipids but not with fatty acids (FA) profiles. Similarly, data on the effect of PNPLA3 I148M polymorphism on blood FAs are scarce. In this study, a gas chromatography-flame ionization detection (GC-FID) method was optimized, allowing us to analyze twenty FAs (C14: 0, C15: 0, C15: 1, C16: 0, C16: 1, C17: 0, C17: 1, C18: 0, C18: 1cis, C18: 2cis, C20: 0, C20: 1n9, C20: 2, C20: 3n6, C20: 4n6, C20: 5, C23: 0, C24: 0, C24: 1 and C22: 6) in whole blood, based on the indirect determination of the fatty acids methyl esters (FAMES), in 62 hyperlipidemic patients and 42 normolipidemic controls. FA concentrations were then compared between the different genotypes of the rs738409 and rs2032582 (ABCB1 G2677T) polymorphisms, within and between the hyperlipidemic and normolipidemic groups. The rs738409 polymorphism appears to exert a significant effect on the distribution of blood fatty acids, in a lipidemic and fatty acid saturation state-depending manner. The effect of rs2032582 was less pronounced, but the polymorphism did appear to affect the relative distribution of blood fatty acids between hyperlipidemic patients and normolipidemic controls.

Entities:  

Keywords:  ABCB1; FAME; GC-FID; PNPLA3; fatty acids profile

Year:  2021        PMID: 33557317      PMCID: PMC7915980          DOI: 10.3390/metabo11020090

Source DB:  PubMed          Journal:  Metabolites        ISSN: 2218-1989


  26 in total

1.  A population-based study on the prevalence of NASH using scores validated against liver histology.

Authors:  Jenni Hyysalo; Ville T Männistö; You Zhou; Johanna Arola; Vesa Kärjä; Marja Leivonen; Anne Juuti; Nabil Jaser; Susanna Lallukka; Pirjo Käkelä; Sari Venesmaa; Marko Simonen; Juha Saltevo; Leena Moilanen; Eeva Korpi-Hyövalti; Sirkka Keinänen-Kiukaanniemi; Heikki Oksa; Marju Orho-Melander; Luca Valenti; Silvia Fargion; Jussi Pihlajamäki; Markku Peltonen; Hannele Yki-Järvinen
Journal:  J Hepatol       Date:  2013-12-12       Impact factor: 25.083

2.  The PNPLA3-I148M Variant Confers an Antiatherogenic Lipid Profile in Insulin-resistant Patients.

Authors:  Panu K Luukkonen; Sami Qadri; Tiina E Lehtimäki; Anne Juuti; Henna Sammalkorpi; Anne K Penttilä; Antti Hakkarainen; Marju Orho-Melander; Johanna Arola; Hannele Yki-Järvinen
Journal:  J Clin Endocrinol Metab       Date:  2021-01-01       Impact factor: 5.958

Review 3.  The degradation of apolipoprotein B100: multiple opportunities to regulate VLDL triglyceride production by different proteolytic pathways.

Authors:  Edward A Fisher
Journal:  Biochim Biophys Acta       Date:  2012-02-10

Review 4.  Diverse relations between ABC transporters and lipids: An overview.

Authors:  Jennifer Neumann; Dania Rose-Sperling; Ute A Hellmich
Journal:  Biochim Biophys Acta Biomembr       Date:  2016-09-29       Impact factor: 3.747

5.  Preparation of fatty acid methyl esters for gas-liquid chromatography.

Authors:  Ken'ichi Ichihara; Yumeto Fukubayashi
Journal:  J Lipid Res       Date:  2009-09-16       Impact factor: 5.922

6.  Transintestinal cholesterol excretion is an active metabolic process modulated by PCSK9 and statin involving ABCB1.

Authors:  Cédric Le May; Jean Mathieu Berger; Anne Lespine; Bruno Pillot; Xavier Prieur; Eric Letessier; M Mahmood Hussain; Xavier Collet; Bertrand Cariou; Philippe Costet
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-04-04       Impact factor: 8.311

Review 7.  The role of PNPLA3 in health and disease.

Authors:  Piero Pingitore; Stefano Romeo
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2018-06-20       Impact factor: 4.698

8.  Inhibitory Regulation of Dendritic Activity in vivo.

Authors:  Lucy Palmer; Masanori Murayama; Matthew Larkum
Journal:  Front Neural Circuits       Date:  2012-05-25       Impact factor: 3.492

9.  The PNPLA3 variant associated with fatty liver disease (I148M) accumulates on lipid droplets by evading ubiquitylation.

Authors:  Soumik BasuRay; Eriks Smagris; Jonathan C Cohen; Helen H Hobbs
Journal:  Hepatology       Date:  2017-08-26       Impact factor: 17.425

10.  Fatty acid profile and estimated desaturase activities in whole blood are associated with metabolic health.

Authors:  Karianne Svendsen; Thomas Olsen; Tove C Nordstrand Rusvik; Stine M Ulven; Kirsten B Holven; Kjetil Retterstøl; Vibeke H Telle-Hansen
Journal:  Lipids Health Dis       Date:  2020-05-21       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.